Target Name: ZNF687
NCBI ID: G57592
Review Report on ZNF687 Target / Biomarker Content of Review Report on ZNF687 Target / Biomarker
ZNF687
Other Name(s): ZN687_HUMAN | Zinc finger protein 687 | RP11-126K1.3 | KIAA1441 | Zinc finger protein 687, transcript variant 1 | Zinc finger protein 687, transcript variant 2 | zinc finger protein 687 | ZNF687 variant 1 | ZNF687 variant 2 | PDB6

ZNF687: A Potential Drug Target and Biomarker

ZNF687 (ZN687_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a member of the ZNF family of proteins, which are known for their role in regulating gene expression and cell growth. ZNF687 has been identified as a potential drug target and biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The ZNF687 protein is composed of 214 amino acid residues and has a calculated molecular weight of 23.9 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and is also found in the placenta and testes. ZNF687 is a scaffold protein that is involved in the regulation of cellular processes, including cell adhesion, migration, and survival.

One of the unique features of ZNF687 is its ability to interact with other proteins. It has been shown to interact with a variety of proteins, including the transcription factor NF-kappa-B and the protein T-cell factor 2 (TFF2). These interactions may play a role in the regulation of cellular processes, including cell growth, differentiation, and inflammation.

In addition to its role in cell regulation, ZNF687 has also been shown to be involved in the development and progression of a variety of diseases. For example, it has been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. It has also been shown to be involved in the development of cancer, including melanoma and breast cancer.

As a potential drug target, ZNF687 is being investigated for its ability to intervene in a variety of diseases. For example, studies have shown that inhibiting the activity of ZNF687 has the potential to treat a variety of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. In addition, ZNF687 has also been shown to be involved in the regulation of cellular processes that may be relevant to the development of cancer. For example, studies have shown that ZNF687 is involved in the regulation of the DNA damage response, a process that is important for the development of cancer.

As a biomarker, ZNF687 is being investigated for its ability to serve as a diagnostic or predictive tool for a variety of diseases. For example, studies have shown that ZNF687 is expressed in a variety of tissues and is highly conserved across different species. This suggests that it may be a useful biomarker for a variety of diseases. In addition, the fact that ZNF687 is involved in the regulation of cellular processes that are relevant to a variety of diseases may make it a useful target for drug development.

In conclusion, ZNF687 is a protein that is expressed in various tissues of the human body and is involved in the regulation of cellular processes that are important for the development and progression of a variety of diseases. As a potential drug target and biomarker, ZNF687 is being investigated for its ability to interfere with the development and progression of these diseases. Further research is needed to fully understand the role of ZNF687 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Zinc Finger Protein 687

Functions: May be involved in transcriptional regulation

The "ZNF687 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF687 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P